Doxorubicin Hydrochloride Injection

Doxorubicin Hydrochloride Injection Specification

Dosage Form
Injection

Salt Composition
Doxorubicin Hydrochloride

Indication
Treatment of various cancers such as breast cancer, bladder cancer, lymphoma, and leukemia

Feature
Sterile, single-use vial

Ingredients
Doxorubicin Hydrochloride, sterile water for injection, excipients

Application

Ph Level
2.5 - 3.5

Physical Color/Texture
Tan liquid

Fermentation Smell
Normal Smell

Storage Instructions
Dry place

Shelf Life
upto 24 Days

Doxorubicin Hydrochloride Injection Trade Information

Minimum Order Quantity
1 Unit

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Units Per Month

Delivery Time
7-10 Seconds

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

Main Domestic Market
All India

About Doxorubicin Hydrochloride Injection

Spotlight your oncology treatment with the sterling Doxorubicin Hydrochloride Injection. Available in 10 mg/5 ml and 50 mg/25 ml vials, its ready-to-use, tan-colored solution is perfect for intravenous chemotherapy against breast, bladder, lymphoma, and leukemia cancers. Manufactured in India, this single-use vial gains favorable reviews for its compatibility with saline and glucose solutions and has a gorgeous simplicity with no reconstitution required. Pick yours today and ensure safety-hospital administration under a qualified physician only. Prescription required. Storage is effortless in a dry place.

Key Features and Application Areas

Doxorubicin Hydrochloride Injection stands out for its sterile, single-use formulation, making it ideal for hospital oncology units. It is effectively used as intravenous chemotherapy in managing breast cancer, bladder cancer, lymphoma, and leukemia. The material's compatibility with normal saline and glucose solutions extends its application versatility. Carefully produced in India, its ready-to-use format ensures swift preparation and simplified logistics when time is of the essence during critical care.

Sample Policy, Payment, and Shipping Information

We offer clear sample policies and flexible payment terms tailored for hospital networks and wholesalers. Transportation estimates are provided at order placement, with prompt dispatching aims for all orders within the main domestic markets. Our streamlined logistics guarantee efficient handling from confirmation to delivery, ensuring your oncology supplies arrive in sterling condition. If you require samples, payment options or dispatch timelines, our support team is available for detailed details and estimate generation.

Specification

Country of Origin	Made in India
Form	Injection
Packaging Size	100ml in 1 Vial
Prescription/Non prescription	Prescription
Treatment	Cancer
Composition	Doxorubicin (50mg)

FAQ's of Doxorubicin Hydrochloride Injection:

Q: How should Doxorubicin Hydrochloride Injection be administered?

A: This injection is intended for intravenous use only and must be administered by a qualified physician in a hospital setting to ensure safety and effective dosing.

Q: What types of cancers can Doxorubicin Hydrochloride Injection treat?

A: It is indicated for the treatment of various cancers, including breast cancer, bladder cancer, lymphoma, and leukemia, making it a versatile choice in oncology therapy.

Q: When is Doxorubicin Hydrochloride Injection contraindicated?

A: The injection should not be used in patients who have hypersensitivity to doxorubicin or any of its excipients. Always consult your healthcare provider for individual assessment.

Q: What is the process for storing Doxorubicin Hydrochloride Injection?

A: Store the vials in a dry place, adhering to standard hospital storage conditions to maintain sterility and medication integrity for up to 24 days.

Q: Where is the Doxorubicin Hydrochloride Injection manufactured and exported from?

A: This product is manufactured in India and is available for export and wholesale, ensuring global access with high manufacturing standards.

Q: What benefits does the ready-to-use formulation provide?

A: The solution does not require reconstitution, allowing immediate administration and reducing preparation time, thus enhancing workflow efficiency in hospital environments.